Login to Your Account

NewCo News

Respiratory Disease Firm Pearl Raises $15.5M In First Financing

By Jennifer Boggs

Friday, September 7, 2007
Formed last year to use particle technologies licensed from Nektar Therapeutics Inc. for respiratory drug development, start-up Pearl Therapeutics Inc. pulled in $15.5 million in its first venture-backed financing round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription